ELANTAS Beck India Past Earnings Performance
Past criteria checks 3/6
ELANTAS Beck India has been growing earnings at an average annual rate of 25.1%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 15.2% per year. ELANTAS Beck India's return on equity is 18.2%, and it has net margins of 20.1%.
Key information
25.1%
Earnings growth rate
25.1%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 15.2% |
| Return on equity | 18.2% |
| Net Margin | 20.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ELANTAS Beck India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 7,307 | 1,468 | 449 | 0 |
| 30 Jun 24 | 7,104 | 1,506 | 429 | 0 |
| 31 Mar 24 | 6,923 | 1,442 | 413 | 0 |
| 31 Dec 23 | 6,852 | 1,373 | 406 | 0 |
| 30 Sep 23 | 6,709 | 1,268 | 368 | 0 |
| 30 Jun 23 | 6,646 | 1,190 | 423 | 0 |
| 31 Mar 23 | 6,622 | 1,041 | 400 | 0 |
| 31 Dec 22 | 6,490 | 978 | 383 | 0 |
| 30 Sep 22 | 6,256 | 879 | 334 | 0 |
| 30 Jun 22 | 6,054 | 805 | 319 | 0 |
| 31 Mar 22 | 5,494 | 725 | 318 | 0 |
| 31 Dec 21 | 5,222 | 669 | 312 | 0 |
| 30 Sep 21 | 4,947 | 728 | 313 | 0 |
| 30 Jun 21 | 4,759 | 744 | 306 | 0 |
| 31 Mar 21 | 4,072 | 666 | 291 | 0 |
| 31 Dec 20 | 3,833 | 618 | 283 | 0 |
| 30 Sep 20 | 3,585 | 498 | 272 | 0 |
| 30 Jun 20 | 3,400 | 428 | 274 | 0 |
| 31 Mar 20 | 4,008 | 509 | 279 | 0 |
| 31 Dec 19 | 3,941 | 496 | 276 | 0 |
| 30 Sep 19 | 4,122 | 534 | 264 | 0 |
| 30 Jun 19 | 4,160 | 500 | 257 | 0 |
| 31 Mar 19 | 4,107 | 493 | 247 | 0 |
| 31 Dec 18 | 4,094 | 658 | 258 | 0 |
| 30 Sep 18 | 3,974 | 658 | 249 | 0 |
| 30 Jun 18 | 3,896 | 684 | 247 | 0 |
| 31 Mar 18 | 3,805 | 688 | 244 | 0 |
| 31 Dec 17 | 3,827 | 551 | 227 | 0 |
| 30 Sep 17 | 3,696 | 522 | 249 | 0 |
| 30 Jun 17 | 3,695 | 542 | 239 | 0 |
| 31 Mar 17 | 3,746 | 560 | 227 | 0 |
| 31 Dec 16 | 3,658 | 545 | 224 | 0 |
| 30 Sep 16 | 3,647 | 526 | 208 | 0 |
| 30 Jun 16 | 3,594 | 480 | 203 | 0 |
| 31 Mar 16 | 3,537 | 466 | 205 | 0 |
| 31 Dec 15 | 3,447 | 418 | 210 | 0 |
| 30 Sep 15 | 3,456 | 408 | 381 | 10 |
| 30 Jun 15 | 3,480 | 375 | 379 | 10 |
| 31 Mar 15 | 3,419 | 342 | 379 | 10 |
| 31 Dec 14 | 3,411 | 316 | 193 | 0 |
| 30 Sep 14 | 3,313 | 296 | 301 | 0 |
| 30 Jun 14 | 3,180 | 285 | 301 | 0 |
| 31 Mar 14 | 3,085 | 285 | 296 | 0 |
| 31 Dec 13 | 3,045 | 318 | 303 | 9 |
Quality Earnings: 500123 has a large one-off gain of ₹415.1M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 500123's current net profit margins (20.1%) are higher than last year (18.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 500123's earnings have grown significantly by 25.1% per year over the past 5 years.
Accelerating Growth: 500123's earnings growth over the past year (15.8%) is below its 5-year average (25.1% per year).
Earnings vs Industry: 500123 earnings growth over the past year (15.8%) exceeded the Chemicals industry 10.4%.
Return on Equity
High ROE: 500123's Return on Equity (18.2%) is considered low.